Evidence map›Paper›PMID 33586566›Full record

ReviewExpert review of clinical pharmacology2021

Concomitant use of dexamethasone and tetracyclines: a potential therapeutic option for the management of severe COVID-19 infection?

Harmanjit Singh, Prerna Chauhan, Jasbir Singh, Saurabh, C S Gautam, Ashish Kumar Kakkar

Open access · greenAbstract readReview
In one paragraph

Review in Expert review of clinical pharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Harmanjit SinghDepartment of Pharmacology, Government Medical College and Hospital, Chandigarh, India.ORCID https://orcid.org/0000-0002-4521-3443
Prerna ChauhanMultidisciplinary Research Unit, Government Medical College and Hospital, Chandigarh, India.
Jasbir SinghDepartment of Pharmacology, Government Medical College and Hospital, Chandigarh, India.
SaurabhDepartment of Neurosurgery, Dayanand Medical College and Hospital, Ludhiana, India.
C S GautamDepartment of Pharmacology, Government Medical College and Hospital, Chandigarh, India.
Ashish Kumar KakkarDepartment of Pharmacology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.ORCID https://orcid.org/0000-0001-7768-7304
Government Medical College and Hospital · INDayanand Medical College & Hospital · INGovernment Medical College and Hospital · INPost Graduate Institute of Medical Education and Research · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19 Drug TreatmentSARS-CoV-2Anti-Bacterial AgentsAnti-Inflammatory AgentsDexamethasoneHumansTetracyclinesAnti-Bacterial AgentsAnti-Inflammatory AgentsDexamethasoneTetracyclinesCytokinesdoxycyclineglucocorticoidsminocyclinesars-CoV-2

Identifiers

PMID33586566
PMCPMC7938652
OpenAlexW3129878548

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.